AGEX THERAPEUTICS INC's ticker is AGE and the CUSIP is 00848H108. A total of 39 filers reported holding AGEX THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $62,970 | -14.1% | 92,603 | +12.8% | 0.01% | -8.3% |
Q2 2023 | $73,317 | +28.5% | 82,083 | -4.6% | 0.01% | +9.1% |
Q1 2023 | $57,035 | -5.8% | 86,026 | -0.5% | 0.01% | -21.4% |
Q4 2022 | $60,516 | +31.6% | 86,440 | +5.4% | 0.01% | +7.7% |
Q3 2022 | $46,000 | -24.6% | 82,010 | -22.7% | 0.01% | -13.3% |
Q2 2022 | $61,000 | -37.8% | 106,038 | -8.0% | 0.02% | -34.8% |
Q1 2022 | $98,000 | -19.7% | 115,213 | +2.6% | 0.02% | -28.1% |
Q4 2021 | $122,000 | +40.2% | 112,251 | +20.8% | 0.03% | +23.1% |
Q3 2021 | $87,000 | -13.9% | 92,940 | +42.6% | 0.03% | -27.8% |
Q2 2021 | $101,000 | +5.2% | 65,187 | +10.2% | 0.04% | -21.7% |
Q1 2021 | $96,000 | +14.3% | 59,148 | +6.6% | 0.05% | -6.1% |
Q4 2020 | $84,000 | +82.6% | 55,492 | -3.2% | 0.05% | +40.0% |
Q3 2020 | $46,000 | +2.2% | 57,325 | +21.6% | 0.04% | -20.5% |
Q2 2020 | $45,000 | – | 47,157 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 2,997,156 | $4,646,000 | 0.21% |
Strategic Wealth Investment Group, LLC | 65,187 | $101,000 | 0.04% |
Defender Capital, LLC. | 34,897 | $54,000 | 0.02% |
Beirne Wealth Consulting Services, LLC | 18,000 | $28,000 | 0.02% |
Prescott General Partners LLC | 185,185 | $287,000 | 0.01% |
Summit X, LLC | 20,500 | $32,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 244,770 | $379,000 | 0.01% |
Piscataqua Savings Bank | 1,000 | $2,000 | 0.00% |
Sigma Planning Corp | 51,700 | $80,000 | 0.00% |
Riggs Asset Managment Co. Inc. | 1,160 | $2,000 | 0.00% |